Joaquin Duato is Worldwide Chairman, Pharmaceuticals, Johnson & Johnson, a position he assumed in January 2011. He is responsible for the global pharmaceutical commercial businesses of the Janssen Pharmaceutical Companies of Johnson & Johnson. In this role, Joaquin also oversees the Operations, Quality, and Compliance functional groups supporting the Pharmaceutical commercial and research and development organizations.
Prior to his current role, Joaquin held the position of Company Group Chairman, The Americas, and led a team responsible for the launches of key products and for the strong growth of major therapeutic franchises throughout Canada, the U.S. and Latin America. He also held the role of Company Group Chairman, Ortho Clinical Diagnostics, Inc.
Joaquin’s career in the pharmaceutical industry has spanned sales, marketing and general management. He joined Johnson & Johnson in 1989 in Janssen Spain and later became Managing Director of Janssen-Cilag Italy. He then led Ortho Biotech Europe before relocating to the United States in 2002 as Vice President for the Ortho Biotech Oncology Franchise. He was named President, Ortho Biotech Products, L.P. in 2005.
Joaquin serves on the Board of Directors of the Pharmaceutical Research & Manufacturers of America (PhRMA) and chairs the PhRMA State Committee. He is also a member of the Board of Trustees of Save the Children and the International Advisory Board of the ESADE Business School.
A native of Valencia, Spain, Joaquin holds an undergraduate degree in Economics and two Master’s degrees – one in Business Administration from ESADE Business School in Barcelona; the other in International Management from Thunderbird in Phoenix, Arizona.
Joaquin News & Multimedia
CNBC's Meg Tirrell speaks to Johnson & Johnson chairman, Joaquin Duato, about J&J's partnership with the National Institutes of Health to fast track its Ebola vaccine program to begin human testing by early 2015.
Joaquin Duato wrote about his trip to Texas to learn about the humanitarian work being done to help children in a Huffington Post globalmotherhood blog.
Johnson & Johnson’s Joaquin Duato and Sarah Colamarino write about the importance of investing in a child’s future from birth through the important developmental years and beyond. Learn how the long-standing partnership between Save the Children and J&J continues to help support children around the globe.